Saeid Akhtari

Saeid Akhtari serves as the Managing Director at HBM Genomics since November 2014. In addition to this role, Akhtari is actively involved in several companies as an Investor or Advisor, including Galatea Bio Inc., Kernal Biologics, Cornerstone AI, Cellanome, Gencove, insitro, PrognomiQ Inc, and Genalyte, Inc. Notably, Akhtari has been an Investor and Advisor for Seer Biosciences since December 2017, contributing to its IPO in December 2020. Educational background includes attendance at the University of Utah.